Expertise

01

Pharmaceutical decisions require connected expertise.

Our work connects strategic, technical, operational, commercial, and market realities. The objective is not a longer list of recommendations. It is a better decision and a controllable route to execution.

How we create value

We bring the functions into the same room—before their assumptions collide in execution.

A portfolio decision changes development priorities. A market choice changes evidence, manufacturing, pack, price, partner, and supply requirements. A technology decision changes data, governance, and operating behaviour. Our role is to make those connections visible early.

01

Strategy & growth

Choose where to play—and what it will take to win.

We help leadership teams turn broad growth ambition into a focused set of choices across markets, categories, channels, capabilities, and investment priorities.

Questions we help answer

  • Which growth spaces are strategically attractive and operationally credible?
  • What should be built, acquired, licensed, partnered, or exited?
  • Which assumptions matter most to the investment case?

Typical outputs

  • Growth thesis and strategic choices
  • Opportunity prioritisation
  • Scenario and risk architecture
  • Execution roadmap and governance
02

Portfolio & product strategy

Build a portfolio around evidence, not enthusiasm.

We connect market need, clinical relevance, technical feasibility, competitive intensity, regulatory pathway, and commercial economics before resources are committed.

Questions we help answer

  • Which assets deserve investment, acceleration, redesign, or removal?
  • Where are the portfolio gaps, overlaps, and concentration risks?
  • How should product concepts be translated into decision-ready briefs?

Typical outputs

  • Portfolio architecture
  • Product opportunity assessment
  • Target product and evidence logic
  • Prioritised development sequence
03

Market entry & access

Approval is one gate. Access is the full system.

We design market-entry pathways that connect regulatory feasibility with route to market, partner economics, reimbursement realities, channel structure, and launch readiness.

Questions we help answer

  • Which market-entry model fits the product, capital base, and risk appetite?
  • What must be true before a distributor, licensee, or commercial partner is appointed?
  • How do regulatory, pricing, channel, and evidence decisions interact?

Typical outputs

  • Market-entry strategy
  • Partner and channel model
  • Access and launch readiness map
  • Decision gates and dependency plan
04

Development, CMC & technology transfer

Translate the product ambition into a controllable programme.

We structure product-development and transfer programmes across formulation, CMC, analytical, manufacturing, stability, documentation, partners, timelines, and governance.

Questions we help answer

  • Is the development pathway technically coherent and submission-aware?
  • Is the manufacturing partner genuinely suitable for the intended market?
  • Where can transfer, scale-up, stability, or documentation fail?

Typical outputs

  • Development and CMC programme design
  • CMO/CDMO evaluation framework
  • Technology-transfer governance
  • Risk register and stage-gate plan
05

Operations, sourcing & resilience

Design the operating model before volume exposes it.

We help companies reduce single-point dependency across suppliers, geographies, routes, inventory, information, and decision rights—without confusing resilience with unnecessary complexity.

Questions we help answer

  • Where is the business structurally fragile?
  • Which capabilities belong in-house, with partners, or in a managed network?
  • How should sourcing, quality, inventory, and information flows be governed?

Typical outputs

  • Operating-model design
  • Strategic sourcing architecture
  • Supply resilience assessment
  • Partner governance and performance model
06

Commercial readiness & launch

Make the launch system ready before the launch date arrives.

We align proposition, evidence, pricing logic, channels, partners, demand assumptions, launch sequencing, and execution ownership into a practical commercial readiness plan.

Questions we help answer

  • Is the proposition specific enough to win with the intended customer?
  • Are forecasts grounded in channel and adoption reality?
  • What must be built, tested, and decided before launch?

Typical outputs

  • Commercial strategy and value proposition
  • Launch readiness assessment
  • Demand and scenario logic
  • Channel and account activation plan
07

Digital, data & AI strategy

Use technology to improve decisions—not decorate them.

We define practical digital and AI use cases around forecasting, portfolio intelligence, traceability, partner visibility, workflow control, and management decision-making.

Questions we help answer

  • Which use cases create measurable operational or strategic value?
  • What data, governance, and workflow conditions are required?
  • Should the capability be bought, built, partnered, or deferred?

Typical outputs

  • Digital and AI opportunity map
  • Use-case prioritisation
  • Data and governance requirements
  • Prototype-to-scale roadmap
08

Partnerships, licensing & diligence

Make the relationship investable before making it contractual.

We help clients frame, evaluate, and govern strategic partnerships, licensing opportunities, manufacturers, distributors, and market-entry counterparties.

Questions we help answer

  • Does the strategic logic survive operational and commercial scrutiny?
  • What diligence matters before exclusivity, investment, or transfer?
  • How should economics, responsibilities, milestones, and governance align?

Typical outputs

  • Strategic and commercial diligence
  • Partner evaluation and shortlist
  • Deal logic and responsibility map
  • Post-signing governance design